BPC-157

BPC-157 (Body Protection Compound-157) is an investigational synthetic pentadecapeptide derived from a sequence found in human gastric juice. It is studied primarily in preclinical models as an injectable or oral candidate. It is being researched for potential tissue repair, wound healing, and regenerative effects on muscles, tendons, ligaments, and gastrointestinal tissues, along with possible anti-inflammatory and cytoprotective properties. As of 2026, BPC-157 remains unapproved by the Therapeutic Goods Administration (TGA) for general use and is classified as a research chemical.